Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy
December 3, 2024
Beyond Air Receives CE Mark in Europe for the LungFit® PH System
December 2, 2024
NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board
November 26, 2024
Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 14, 2024
Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update
November 11, 2024
Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 11, 2024
Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast
October 29, 2024
Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 7, 2024
Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks
October 2, 2024
Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed
September 27, 2024

Sign up for updates from Beyond Air, Inc.

Unsubscribe from all email communications. Unsubscribe